Every piece links its primary source at the top and answers one question: what changes for a plant.
Scale-Up & CapacityBrief
KRW 2.71 trillionOf the KRW 3 trillion rights offering, about KRW 2.71 trillion is allocated to the planned PolyPeptide acquisition and about KRW 290 billion goes to Bio Campus II.
Bioprocess 4.0Explainer
Scale-Up & CapacityBrief
18,000 LBioprocess 4.0Brief
23.2%Bioprocess 4.0Brief
40+USP and DSP scale-up, new plants, CDMO capacity, reshoring and the policy behind it.
PAT, automation, AI, digital twins, process data and how to validate them.
Industrial scale-up, capacity and economics of precision and biomass fermentation.
Biomanufacturing and pharma manufacturing moves in Spain, Portugal and Italy.